Vp (VP) H2 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 TU earnings summary
17 Apr, 2026Executive summary
Expects FY26 profit before tax, amortisation, impairment, and exceptional items between £26-29m, aligning with revised guidance.
Maintained operational and financial discipline amid challenging macroeconomic conditions.
Strategic focus on infrastructure-led markets and digital transformation continues.
Financial highlights
Profit guidance for FY26 set at £26-29m, consistent with previous revisions.
Balance sheet remains strong, supporting disciplined investment and value creation.
Outlook and guidance
Board remains confident in future performance due to diversified model and infrastructure exposure.
Market conditions remain mixed, but long-term demand drivers are intact.
Infrastructure sector, especially electricity transmission, shows growth and strong demand.
Water sector expected to improve revenues in FY27 as AMP8 progresses.
Latest events from Vp
- VP Rail launch and CPH acquisition drive growth amid robust results and sector challenges.VP
Investor Update9 Jul 2026 - Restructuring and international growth offset UK headwinds, supporting stable full-year outlook.VP
H1 20268 Jul 2026 - International profit up 30% and Brandon restructure completed amid UK market challenges.VP
H2 202612 Jun 2026 - Profit guidance lowered to £26-29m amid slow sector activity; Brandon transformation on track.VP
Trading update11 Feb 2026 - Resilient FY24 with £368.7m revenue, strong cash flow, and strategic transformation.VP
H2 202431 Jan 2026 - Strong H1, resilient returns, Ireland acquisition, and growth in infrastructure and energy.VP
H1 202512 Jan 2026 - Resilient results, strong infrastructure momentum, and strategic growth in Ireland and Germany.VP
H2 202513 Nov 2025 - Solid first-half performance and positive outlook, with full-year expectations unchanged.VP
Trading Update13 Oct 2025 - First half performance solid; outlook positive with H2 growth expected in key segments.VP
Q2 2026 TU10 Oct 2025